Case Reports in Gastrointestinal Medicine

Case Reports in Gastrointestinal Medicine / 2017 / Article

Case Report | Open Access

Volume 2017 |Article ID 9615359 | 8 pages | https://doi.org/10.1155/2017/9615359

Gastric Schwannoma: A Tumor Must Be Included in Differential Diagnoses of Gastric Submucosal Tumors

Academic Editor: Naohiko Koide
Received01 Mar 2017
Accepted23 Apr 2017
Published09 May 2017

Abstract

Gastric schwannoma (GS) is a rare neoplasm of the stomach. It accounts for 0.2% of all gastric tumors and is mostly benign, slow-growing, and asymptomatic. Due to its rarity, GS is not widely recognized by clinicians, and the precise differential diagnosis between GS and other gastric submucosal tumors remains difficult preoperatively. The present study reports a case of GS misdiagnosed as gastrointestinal stromal tumor and reviews the clinical, imaging, and pathological features, treatment, and follow-up of 221 patients with GS previously reported in the English literature. Although GS is rare, the case reported in the current study highlights the importance of including GS in differential diagnoses of gastric submucosal tumors. Furthermore, the findings of the review suggest that although many cases are asymptomatic, the most common symptoms are abdominal pain or discomfort, not gastrointestinal bleeding, and malignant GSs present with clinical symptoms more commonly. Although large-sample multicenter studies on the efficacy, safety, and oncological outcomes of minimally invasive techniques are required, the findings presented herein may be helpful for clinicians when diagnosing or treating GS.

1. Introduction

Gastric schwannoma (GS) is a rare submucosal tumor that arises from Schwann cells in the neural plexus of the stomach. It accounts for only 0.2% of all gastric tumors, 6.3% of gastric mesenchymal tumors, and 4% of all benign tumors of the stomach [1]. GS was first described in 1988 in a study by Daimaru et al. [2], in which a series of 24 cases were examined. To date, more than 200 new cases of GS have been reported worldwide, and the findings of imaging findings and analysis of the gross features of GS have been described in some sporadic case reports and the occasional series of GS cases. However, GS is not widely recognized by clinicians, and it remains difficult to accurately distinguish GS from other gastric submucosal tumors preoperatively.

The present study reports the case of a 61-year-old woman with GS and reviews the current knowledge of GS available based on sporadic case reports and the occasional series of case reports in the literature. We hope that the findings will be useful for clinicians during the diagnosis and treatment of GS.

2. Case Report

A 61-year-old woman with a 2-year history of nonspecific epigastric abdominal pain underwent esophagogastroduodenoscopy (EGD) to rule out a digestive ulcer. EGD revealed a submucosal bulge on the anterior wall of the gastric body (Figure 1(a)). The patient then underwent endosonography, which revealed a large submucosal mass measuring 3.7 × 3.2 cm arising from the muscularis propria (the fourth layer). The features of the mass were similar to those of a gastrointestinal stromal tumor (GIST) (Figure 1(b)).

A computed tomography (CT) scan revealed a uniformly enhancing mass located between the left lobe of the liver and the lesser curvature of the gastric body. The mass was partly exophytic and partly projected into the gastric lumen, causing smooth indentation, and measured 4.3 × 3.2 cm (Figure 2). The patient’s laboratory results were unremarkable. Based on the above data, the patient was given a preoperative diagnosis of GIST arising from the anterior wall of the gastric body.

The patient was then subjected to laparoscopic examination, which showed an exophytic tumor (4 × 3 cm size) arising from the anterior wall of the lesser gastric curvature. The exophytic part of the mass appeared off-white in color and rough, with a concavo-convex surface; however, the margin of the mass on the gastric wall was clear (Figure 3(a)). To achieve an optimal tumor-negative margin, the laparoscopy was converted to a laparotomy, and complete resection of the tumor was performed. Histopathology revealed that the tumor was composed of spindle cells in a palisading arrangement, and peritumoral cuff-like lymphocytic infiltration was also observed (Figure 3(b)). Immunohistochemical (IHC) staining showed that the spindle cells were positive for S-100 (Figure 3(c)) and negative for CD34, CD117, desmin, DOG1, Ki-67, and smooth muscle actin (SMA) (Figures 3(d)3(i)), which confirmed a diagnosis of GS. The patient had an uneventful recovery and the 1-year follow-up examination was unremarkable.

3. Discussion

A review of the existing literature identified a total of 221 cases of GS (Table 1). The mean age of the patients was years (range, 10–90 years), and 191 of the 221 patients (86.43%) were aged > 40 years. Thus, it appears that GS predominantly affects adults in the fifth to eighth decades of life. The cases comprised 68 males and 153 females, with an approximate sex ratio of 1 : 2.64. Although the sex ratio in certain case series of GS has been reported as ~1 : 4 [1], we hypothesized that the gender predilection may be reduced as more cases are reported. Of the 221 reported cases, detailed clinical information was available for 164 cases. In 71 (43.3%) out of 164 cases, GS was identified incidentally, whereas 22 of the patients (11.6%) initially presented with multiple symptoms [321], 34 (20.7%) presented with one symptom, including abdominal pain or discomfort, and 21 cases (12.8%) were reported with gastrointestinal bleeding. These findings indicate that the majority of cases of GS are asymptomatic and that the most common initial symptom is abdominal pain or discomfort, not gastrointestinal bleeding, which differs from the findings of other case series [16]. The other symptoms, which were more rare, included palpable abdominal mass (3.05%), poor appetite (3.05%), dyspepsia (1.82%), weight loss (1.21%), and nausea or vomiting (0.6%). Recently, Yang et al. [21] reported a case of gastroduodenal intussusception due to GS, which, to the best of our knowledge, is the only case reported in English literature. In addition, we found only 1 case in which the patient initially presented with elevated serum carbohydrate antigen 19-9 preoperatively [22].


BenignMalignantOverall value

Total21110221
Male/female63/1485/568/1530.178
Average age (years)57.13 ± 13.1249.78 ± 22.4456.82 ± 13.770.118
Symptoms (cases)0.695
NA56157 (34.76%)
Multiple symptoms19322 (13.41%)
Asymptomatic (incidentally found)69271 (43.29%)
Abdominal pain or discomfort32234 (20.73%)
GI bleeding19221 (12.80%)
Palpable mass505 (3.05%)
Poor appetite505 (3.05%)
Dyspepsia303 (1.82%)
Weight loss202 (1.22%)
Nausea or vomiting101 (0.6%)
Location (cases)0.581
NA83386 (52.44%)
Subcardia202 (1.22%)
Fundus15015 (9.15%)
Body82587 (53.05%)
Antrum29231 (18.90%)
Size (diameter, cm)0.897
Mean size4.66 ± 2.624.66 ± 1.974.67 ± 2.60
Median size444
Follow-up time (months)0.102
Mean time78.19 ± 84.8544.67 ± 38.0274.67 ± 82.59
Median time432838.5

NA: not available.

GS typically grows as a solitary lesion and is commonly located in the body of the stomach. In the current review, we found only 1 case that reported the presence of two GS lesions in the same patient [23]. The most common site of GS among all of the cases was the gastric body (59.3%), followed by the gastric antrum (26.7%) and fundus (12.0%). GS arising from the cardia was rare (2%). Additionally, the tumor size was variable: the greatest diameter size ranged from 0.8 to 15.5 cm, with a mean of  cm (median: 4.0 cm).

GSs are usually benign and patients have an excellent prognosis after curative resection. Nevertheless, we identified 10 reported cases of malignant GS in the last several decades [4, 12, 24, 25], which represented 4.5% of all reported GSs. In the cases of malignant GS, 5 patients were male and 5 were females, with a mean age of years (range, 10–73 years). Among these cases, the earliest metastasis and recurrence were detected at 3 months after surgery [12]. These patients commonly presented with clinical symptoms such as abdominal pain and gastrointestinal bleeding. Thus, although this should not be considered definitive criteria by which to classify the tumors as benign or malignant, the presence of such clinical symptoms may provide valuable cues for clinicians.

The features of GS shown by imaging, including CT, magnetic resonance imaging (MRI), and [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET), have been clearly described in several isolated case reports and some case series [2634]. Briefly, during CT imaging, GS most commonly presented as a well-circumscribed mass with mild enhancement during the arterial phase and strengthened progressive enhancement during the venous and delayed phases. On MRI, GS typically exhibited low signal intensity on T1-weighted images and high signal intensity on T2-weighted images, which could provide further information regarding its relationship with the surrounding structures and the internal features of GS, such as signs of hemorrhage, necrosis, cystic changes, or calcification [29]. FDG-PET was usually used to evaluate the malignant potential of the lesion and to detect the recurrence or metastasis of malignant tumors [32]. Although GS, as a benign lesion, should not be FDG-avid, it was reported in certain studies that GS exhibited a relatively high accumulation of FDG during PET imaging [28, 29, 32, 35, 36] and that FDG accumulation in GS was not significantly different when compared to other submucosal lesions, such as GIST and leiomyoma [37]. Therefore, FDG-PET may be of limited value as preoperative diagnostic technique for the assessment of GS.

Endoscopic ultrasonography (EUS) is considered to be the most reliable procedure for the assessment of patients with gastrointestinal submucosal lesions [3840], and the EUS features of GS have been systematically summarized in several case series reports [38, 4144]. In these reports, GS commonly appeared on EUS as a round submucosal lesion arising from the fourth layer, with homogeneous internal echogenicity but without internal echogenic foci. Additionally, the echogenicity of the GS was generally lower than that of the surrounding normal muscle layers [38, 45]. Jung et al. [40] hypothesized that these findings may be helpful for differentiating GS from GIST. However, we were unfortunately unable to do so using EUS in the current described case.

Regarding its gross appearance, GS commonly presents as a yellow-white or off-white, solid, well-circumscribed, and round mural mass. Microscopic examination demonstrates that the typical cytological/morphological features of GS are palisade-arranged spindle cells and peritumoral cuff-like lymphocytic infiltration [46]. On histopathological sections, the spindle cells are predominantly located at the center of the lesion and often appear light red with hematoxylin and eosin staining in the cytoplasm. The nuclei of the spindle cells may exhibit a low degree of atypia and mitotic figures are rarely visible (<15/50 high-power fields); these are considered to be the criteria for classifying the tumor as benign or malignant [16]. On IHC sections, GSs are S-100-positive but are CD34-, CD117-, SMA-, and desmin-negative; detection of these markers is widely considered to be the gold standard for diagnosis of GS [46].

Complete surgical resection is widely considered to be a curative treatment for GS, and laparoscopic or open approaches for wedge resection, subtotal gastrectomy or near-total resection, and total gastrectomy are the treatments of choice [5, 9, 4751]. As GS rarely metastasizes to the lymph nodes, surgical lymphadenectomy is not routinely performed and is only considered if enlarged lymph nodes are observed. Recently, minimally invasive surgical approaches, including endoscopic submucosal tunneling resection [52, 53], endoscopic enucleation [54], and endoscopic full-thickness resection with [5557] or without [5860] laparoscopic assistance, have been actively used as diagnostic tools and therapeutic interventions for GS. Based on short-term follow-up observations, these approaches were not associated with any severe postoperative complications. Nevertheless, to date, no large-sample multicenter studies on the efficacy, safety, and oncological outcomes of these minimally invasive surgical approaches have been published. We therefore suggest that these approaches should not be a first choice and should only be used if the diagnosis of GS is definitively confirmed.

A paper published in 2015 by Hong et al. [17] reviewed 137 cases of GS and did not identify recurrence or metastasis in any patients during a follow-up period ranging from 1 to 336 months. The authors therefore concluded that benign GS does not usually recur and, thus, frequent follow-up with CT imaging is not recommended [17]. For the current review, we retrieved 126 cases that reported detailed follow-up information, ranging from 1 to 420 months, from medical literature published in English. Recurrence and metastasis were only observed in malignant GS and not in benign cases of GS, which was similar to the results reported by Hong et al. [17]. The follow-up times in cases of malignant GS ranged from 5 to 120 months, and only 3 out of 10 patients died due to metastasis or recurrence of GS within 5 years after surgery. The earliest recurrence was detected at 3 months after surgery. In addition, Choi et al. [31] reported that the mean doubling time of GS tumors was nearly 5 years, based on CT images with a series of follow-ups. We therefore suggest that the follow-up should be conducted over a period of at least 5 years for cases of malignant GS. However, further research is necessary in order to better understand the features of malignant GS.

4. Conclusion

Although GS is rare, the case reported in the current study highlights the importance of including GS in differential diagnoses of gastric submucosal tumors. Furthermore, the following points regarding GS should be noted: (i) the magnitude of the gender predilection may be reduced as more cases are reported; (ii) the most common symptom is abdominal pain or discomfort, but not gastrointestinal bleeding; (iii) patients with malignant GS commonly present with some clinical symptoms; (iv) although endoscopic submucosal tunneling resection, endoscopic enucleation, and endoscopic full-thickness resection, with or without laparoscopic assistance, have been actively performed as diagnostic and therapeutic techniques for GS, large-sample multicenter studies on the efficacy, safety, and oncological outcomes are still required.

Abbreviations

GS:Gastric schwannoma
GIST:Gastrointestinal stromal tumor
ESD:Endoscopic submucosal dissection
EGD:Esophagogastroduodenoscopy
CT:Computed tomography
IHC:Immunohistochemistry
MRI:Magnetic resonance imaging
FDG-PET:[18F]-Fluorodeoxyglucose positron emission tomography
EUS:Endoscopic ultrasonography
HPFs:High-power fields
SMA:Smooth muscle actin.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Authors’ Contributions

Bao-guang Hu contributed to the concept and manuscript writing. Feng-jie Wu and Jun Zhu contributed to the collection of the clinical data and histological analysis. Yu-ming Li contributed to the critical revision and final approval of the manuscript. Xiao-mei Li, Yan Feng, and He-sheng Li contributed to the collection and analysis of case data and imaging data.

Acknowledgments

The authors thank Professor Nai-guo Liu and his colleagues in clinical laboratory of the Affiliated Hospital of Binzhou Medical University for their kind help in the present study. This work was supported by the Project of Medical and Health Technology Development Program in Shandong Province (Grant no. 2015WS0483) and Scientific Research Starting Foundation of Binzhou Medical University (Grant no. BY2014KYQD37).

References

  1. M. R. Sreevathsa and G. Pipara, “Gastric schwannoma: a case report and review of literature,” Indian Journal of Surgical Oncology, vol. 6, no. 2, pp. 123–126, 2015. View at: Publisher Site | Google Scholar
  2. Y. Daimaru, H. Kido, H. Hashimoto, and M. Enjoji, “Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study,” Human Pathology, vol. 19, no. 3, pp. 257–264, 1988. View at: Publisher Site | Google Scholar
  3. D. Radulescu, M. Stoian, and M. Sarbu, “Gastric malignant schwannoma,” Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi, vol. 99, pp. 221–225, 1995. View at: Google Scholar
  4. N. R. Bees, C. S. Ng, C. Dicks-Mireaux, and E. M. Kiely, “Gastric malignant schwannoma in a child,” British Journal of Radiology, vol. 70, pp. 952–955, 1997. View at: Publisher Site | Google Scholar
  5. G. Silecchia, A. Materia, A. Fantini et al., “Laparoscopic resection of solitary gastric schwannoma,” Journal of Laparoendoscopic and Advanced Surgical Techniques - Part A, vol. 7, no. 4, pp. 257–263, 1997. View at: Publisher Site | Google Scholar
  6. G. Rymarczyk, M. Hartleb, H. Boldys, M. Kajor, and A. Wodolazski, “Neurogenic tumors of the digestive tract: report of two cases,” Medical Science Monitor, vol. 6, no. 2, pp. 383–385, 2000. View at: Google Scholar
  7. C. A. Iwamoto, C. F. Garcia, and M. Razzak, “Pathologic quiz case: a 23-year-old woman with a polypoid gastric mass,” Archives of Pathology & Laboratory Medicine, vol. 127, no. 1, pp. e43–44, 2003. View at: Google Scholar
  8. Y. Fujii, N. Taniguchi, Y. Hosoya et al., “Gastric schwannoma: Sonographic findings,” Journal of Ultrasound in Medicine, vol. 23, no. 11, pp. 1527–1530, 2004. View at: Publisher Site | Google Scholar
  9. A. A. Khan, A. M. P. Schizas, A. B. Cresswell, M. K. Khan, and H. T. Khawaja, “Digestive tract schwannoma,” Digestive Surgery, vol. 23, no. 4, pp. 265–269, 2006. View at: Publisher Site | Google Scholar
  10. Y.-Y. Chen, H.-H. Yen, and M.-S. Soon, “Solitary gastric melanotic schwannoma: sonographic findings,” Journal of Clinical Ultrasound, vol. 35, no. 1, pp. 52–54, 2007. View at: Publisher Site | Google Scholar
  11. A. Agaimy, B. Märkl, J. Kitz et al., “Peripheral nerve sheath tumors of the gastrointestinal tract: a multicenter study of 58 patients including NF1-associated gastric schwannoma and unusual morphologic variants,” Virchows Archiv, vol. 456, no. 4, pp. 411–422, 2010. View at: Publisher Site | Google Scholar
  12. M. Takemura, K. Yoshida, M. Takii, K. Sakurai, and A. Kanazawa, “Gastric malignant schwannoma presenting with upper gastrointestinal bleeding: a case report,” Journal of Medical Case Reports, vol. 6, article 37, 2012. View at: Publisher Site | Google Scholar
  13. L. Voltaggio, R. Murray, J. Lasota, and M. Miettinen, “Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature,” Human Pathology, vol. 43, no. 5, pp. 650–659, 2012. View at: Publisher Site | Google Scholar
  14. W. Yoon, K. Paulson, P. Mazzara, S. Nagori, M. Barawi, and R. Berri, “Gastric schwannoma: a rare but important differential diagnosis of a gastric submucosal mass,” Case Reports in Surgery, vol. 2012, Article ID 280982, 5 pages, 2012. View at: Publisher Site | Google Scholar
  15. J. F. Alvarez and K. Ben-David, “Gastric schwannoma: a rare find,” Journal of Gastrointestinal Surgery, vol. 17, no. 12, pp. 2179–2181, 2013. View at: Publisher Site | Google Scholar
  16. L. Zheng, X. Wu, M. E. Kreis et al., “Clinicopathological and immunohistochemical characterisation of gastric schwannomas in 29 cases,” Gastroenterology Research and Practice, vol. 2014, Article ID 202960, 7 pages, 2014. View at: Publisher Site | Google Scholar
  17. X. Hong, W. Wu, M. Wang, Q. Liao, and Y. Zhao, “Benign gastric schwannoma: how long should we follow up to monitor the recurrence? A case report and comprehensive review of literature of 137 cases,” International Surgery, vol. 100, no. 4, pp. 744–747, 2015. View at: Publisher Site | Google Scholar
  18. M. Manji, A. Ismail, and E. Komba, “Gastric Schwannoma: case report from Tanzania and brief review of literature,” Clinical Case Reports, vol. 3, no. 7, pp. 562–565, 2015. View at: Publisher Site | Google Scholar
  19. D. Özyörük, H. A. Demir, S. Emir, D. Koyuncu, and B. Tunç, “Gastric schwannoma without neurofibromatosis in a 16-year-old adolescent,” Journal of Pediatric Hematology/Oncology, vol. 37, no. 7, pp. 570–571, 2015. View at: Publisher Site | Google Scholar
  20. D. Sousa, M. Allen, A. Pinto et al., “Two synchronous colonic adenocarcinomas, a gastric schwannoma and a mucinous neoplasm of the appendix: a case report,” Journal of Gastrointestinal Cancer, vol. 46, no. 3, pp. 304–309, 2015. View at: Publisher Site | Google Scholar
  21. J.-H. Yang, M. Zhang, Z.-H. Zhao, Y. Shu, J. Hong, and Y.-J. Cao, “Gastroduodenal intussusception due to gastric schwannoma treated by billroth II distal gastrectomy: one case report,” World Journal of Gastroenterology, vol. 21, no. 7, pp. 2225–2228, 2015. View at: Publisher Site | Google Scholar
  22. M. Fukuchi, H. Naitoh, H. Shoji et al., “Schwannoma of the stomach with elevated preoperative serum carbohydrate antigen 19-9: report of a case,” Surgery Today, vol. 42, no. 8, pp. 788–792, 2012. View at: Publisher Site | Google Scholar
  23. G. Tozbikian, Rulong Shen and S. Suster, “Signet ring cell gastric schwannoma: report of a new distinctive morphological variant,” Annals of Diagnostic Pathology, vol. 12, no. 2, pp. 146–152, 2008. View at: Publisher Site | Google Scholar
  24. R. J. L. F. Loffeld, T. G. Balk, J. L. T. Oomen, and A. B. M. M. Van Der Putten, “Upper gastrointestinal bleeding due to a malignant Schwannoma of the stomach,” European Journal of Gastroenterology and Hepatology, vol. 10, no. 2, pp. 159–162, 1998. View at: Publisher Site | Google Scholar
  25. A. Watanabe, H. Ojima, S. Suzuki et al., “An individual with gastric schwannoma with pathologically malignant potential surviving two years after laparoscopy-assisted partial gastrectomy,” Case Reports in Gastroenterology, vol. 5, no. 2, pp. 502–507, 2011. View at: Publisher Site | Google Scholar
  26. H. S. Hong, H. K. Ha, H. J. Won et al., “Gastric schwannomas: radiological features with endoscopic and pathological correlation,” Clinical Radiology, vol. 63, no. 5, pp. 536–542, 2008. View at: Publisher Site | Google Scholar
  27. N. Karabulut, D. R. Martin, and M. Yang, “Gastric schwannoma: MRI findings,” British Journal of Radiology, vol. 75, no. 895, pp. 624–626, 2002. View at: Publisher Site | Google Scholar
  28. I. K. Hong and D. Y. Kim, “F-18 FDG PET/CT of a gastric schwannoma,” Nuclear Medicine and Molecular Imaging, vol. 45, no. 3, pp. 238–240, 2011. View at: Publisher Site | Google Scholar
  29. M. Takeda, Y. Amano, T. Machida, S. Kato, Z. Naito, and S. Kumita, “CT, MRI, and PET findings of gastric schwannoma,” Japanese Journal of Radiology, vol. 30, no. 7, pp. 602–605, 2012. View at: Publisher Site | Google Scholar
  30. S. Fujiwara, K. Nakajima, T. Nishida et al., “Gastric schwannomas revisited: has precise preoperative diagnosis become feasible?” Gastric Cancer, vol. 16, no. 3, pp. 318–323, 2013. View at: Publisher Site | Google Scholar
  31. J. W. Choi, D. Choi, K.-M. Kim et al., “Small submucosal tumors of the stomach: differentiation of gastric schwannoma from gastrointestinal stromal tumor with CT,” Korean Journal of Radiology, vol. 13, no. 4, pp. 425–433, 2012. View at: Publisher Site | Google Scholar
  32. J. Yap, Y.-T. T. O. Huang, and M. Lin, “Detection of synchronous gastric schwannoma on FDG PET/CT aided by discordant metabolic response,” Clinical nuclear medicine, vol. 40, no. 5, pp. e287–e289, 2015. View at: Publisher Site | Google Scholar
  33. J.-S. Ji, C.-Y. Lu, W.-B. Mao, Z.-F. Wang, and M. Xu, “Gastric schwannoma: CT findings and clinicopathologic correlation,” Abdominal Imaging, vol. 40, no. 5, pp. 1164–1169, 2015. View at: Publisher Site | Google Scholar
  34. Y. R. Choi, S. H. Kim, S.-A. Kim et al., “Differentiation of large (≥5 cm) gastrointestinal stromal tumors from benign subepithelial tumors in the stomach: radiologists' performance using CT,” European Journal of Radiology, vol. 83, no. 2, pp. 250–260, 2014. View at: Publisher Site | Google Scholar
  35. Y. Shimada, S. Sawada, S. Hojo et al., “Glucose transporter 3 and 1 may facilitate high uptake of 18F-FDG in gastric schwannoma,” Clinical Nuclear Medicine, vol. 38, no. 11, pp. e417–e420, 2013. View at: Publisher Site | Google Scholar
  36. D. Komatsu, N. Koide, R. I. Hiraga et al., “Gastric schwannoma exhibiting increased fluorodeoxyglucose uptake,” Gastric Cancer, vol. 12, no. 4, pp. 225–228, 2009. View at: Publisher Site | Google Scholar
  37. Y. Zhang, B. Li, L. Cai, X. Hou, H. Shi, and J. Hou, “Gastric Schwannoma mimicking malignant gastrointestinal stromal tumor and misdiagnosed by 18F-FDG PET/CT,” Hellenic Journal of Nuclear Medicine, vol. 18, no. 1, pp. 74–76, 2015. View at: Google Scholar
  38. H. Park, D. Son, H. Oh et al., “Endoscopic ultrasonographic characteristics of gastric schwannoma distinguished from gastrointestinal stromal tumor,” Korean Journal of Gastroenterology, vol. 65, no. 1, p. 21, 2015. View at: Publisher Site | Google Scholar
  39. B. Li, T. Liang, L. Wei et al., “Endoscopic interventional treatment for gastric schwannoma: a single-center experience,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 10, pp. 6616–6625, 2014. View at: Google Scholar
  40. M. K. Jung, S. W. Jeon, C. M. Cho et al., “Gastric schwannomas: endosonographic characteristics,” Abdominal Imaging, vol. 33, no. 4, pp. 388–390, 2008. View at: Publisher Site | Google Scholar
  41. Y. Miyamoto, F. Tsujimoto, and S. Tada, “Ultrasonographic diagnosis of submucosal tumors of the stomach: the ‘bridging layers’ sign,” Journal of Clinical Ultrasound, vol. 16, no. 4, pp. 251–258, 1988. View at: Publisher Site | Google Scholar
  42. G. H. Kim, K. B. Kim, S. H. Lee et al., “Digital image analysis of endoscopic ultrasonography is helpful in diagnosing gastric mesenchymal tumors,” BMC Gastroenterology, vol. 14, no. 1, article 7, 2014. View at: Publisher Site | Google Scholar
  43. D.-D. Zhong, C.-H. Wang, J.-H. Xu, M.-Y. Chen, and J.-T. Cai, “Endoscopic ultrasound features of gastric schwannomas with radiological correlation: a case series report,” World Journal of Gastroenterology, vol. 18, no. 48, pp. 7397–7401, 2012. View at: Publisher Site | Google Scholar
  44. J. Barbosa, J. Maciel, and M. Amarante Jr., “Endoscopic ultrasonography in the study of extramucosal swellings in the upper digestive tract,” Surgical Endoscopy, vol. 9, no. 11, pp. 1193–1196, 1995. View at: Publisher Site | Google Scholar
  45. T. Okai, T. Minamoto, K. Ohtsubo et al., “Endosonographic evaluation of c-kit-positive gastrointestinal stromal tumor,” Abdominal Imaging, vol. 28, no. 3, pp. 301–307, 2003. View at: Publisher Site | Google Scholar
  46. E. Rodriguez, S. Tellschow, D. M. Steinberg, and E. Montgomery, “Cytologic findings of gastric schwannoma: a case report,” Diagnostic Cytopathology, vol. 42, no. 2, pp. 177–180, 2014. View at: Publisher Site | Google Scholar
  47. Y. Otani, M. Ohgami, N. Igarashi et al., “Laparoscopic wedge resection of gastric submucosal tumors,” Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, vol. 10, pp. 19–23, 2000. View at: Google Scholar
  48. C. J. Li, M. T. Huang, C. S. Chen, K. W. Tam, C. Y. Chai, and C. H. Wu, “Application of laparoscopic techniques for resection of individual gastric submucosal tumors,” Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, vol. 17, pp. 425–429, 2007. View at: Google Scholar
  49. H. Y. Yoon, C. B. Kim, Y. H. Lee, and H. G. Kim, “Gastric Schwannoma,” Yonsei Medical Journal, vol. 49, no. 6, pp. 1052–1054, 2008. View at: Publisher Site | Google Scholar
  50. Y. Miyazaki, K. Nakajima, Y. Kurokawa et al., “Clinical significance of surgery for gastric submucosal tumours with size enlargement during watchful waiting period,” European Journal of Cancer, vol. 49, no. 12, pp. 2681–2688, 2013. View at: Publisher Site | Google Scholar
  51. A. Takata, K. Nakajima, Y. Kurokawa et al., “Single-incision laparoscopic partial gastrectomy for gastric submucosal tumors without compromising transumbilical stapling,” Asian Journal of Endoscopic Surgery, vol. 7, no. 1, pp. 25–30, 2014. View at: Publisher Site | Google Scholar
  52. J. Lu, T. Jiao, Y. Li et al., “Heading toward the right direction—Solution package for endoscopic submucosal tunneling resection in the stomach,” PLoS ONE, vol. 10, no. 3, Article ID e0119870, 2015. View at: Publisher Site | Google Scholar
  53. B.-R. Liu, J.-T. Song, L.-J. Kong, F.-H. Pei, X.-H. Wang, and Y.-J. Du, “Tunneling endoscopic muscularis dissection for subepithelial tumors originating from the muscularis propria of the esophagus and gastric cardia,” Surgical Endoscopy and Other Interventional Techniques, vol. 27, no. 11, pp. 4354–4359, 2013. View at: Publisher Site | Google Scholar
  54. C. Sun, Z. He, Z. Zheng et al., “Endoscopic submucosal dissection for gastrointestinal mesenchymal tumors adjacent to the esophagogastric junction: we need to do more,” Journal of Laparoendoscopic and Advanced Surgical Techniques, vol. 23, no. 7, pp. 570–577, 2013. View at: Publisher Site | Google Scholar
  55. N. Abe, H. Takeuchi, O. Yanagida et al., “Endoscopic full-thickness resection with laparoscopic assistance as hybrid NOTES for gastric submucosal tumor,” Surgical Endoscopy, vol. 23, no. 8, pp. 1908–1913, 2009. View at: Publisher Site | Google Scholar
  56. L.-Y. Huang, J. Cui, C.-R. Wu et al., “Endoscopic full-thickness resection and laparoscopic surgery for treatment of gastric stromal tumors,” World Journal of Gastroenterology, vol. 20, no. 25, pp. 8253–8259, 2014. View at: Publisher Site | Google Scholar
  57. J. S. Barajas-Gamboa, G. Acosta, T. J. Savides et al., “Laparo-endoscopic transgastric resection of gastric submucosal tumors,” Surgical Endoscopy and Other Interventional Techniques, vol. 29, no. 8, pp. 2149–2157, 2015. View at: Publisher Site | Google Scholar
  58. P. H. Zhou, L. Q. Yao, X. Y. Qin et al., “Endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors originated from the muscularis propria,” Surgical Endoscopy and Other Interventional Techniques, vol. 25, no. 9, pp. 2926–2931, 2011. View at: Publisher Site | Google Scholar
  59. C. K. Lee, S.-H. Lee, I.-K. Chung et al., “Endoscopic full-thickness resection of a gastric subepithelial tumor by using the submucosal tunnel technique with the patient under conscious sedation (with video),” Gastrointestinal Endoscopy, vol. 75, no. 2, pp. 457–459, 2012. View at: Publisher Site | Google Scholar
  60. Y. Feng, L. Yu, S. Yang et al., “Endolumenal endoscopic full-thickness resection of muscularis propria-originating gastric submucosal tumors,” Journal of Laparoendoscopic and Advanced Surgical Techniques, vol. 24, no. 3, pp. 171–176, 2014. View at: Publisher Site | Google Scholar

Copyright © 2017 Bao-guang Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1670 Views | 527 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.